AWA
CRL icon

Alta Wealth Advisors’s Charles River Laboratories CRL Stock Holding History

Alta Wealth Advisors’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-870
Closed -$236K – 122
2024
Q1 		$236K Hold
870
– – 0.12% 119
2023
Q4 		$206K Buy
+870
New +$171K 0.11% 123

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.6B AUM 15.71% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.4B AUM 49.36% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Alta Wealth Advisors's CRL Position: Q2 2024 in Review

Alta Wealth Advisors sold out of Charles River Laboratories (CRL) in Q2 2024, closing a stake of 870 shares — an estimated $236K sold.

Alta Wealth Advisors first reported a position in CRL in Q4 2023 and held it in 2 quarters. The position peaked at $236K in Q1 2024. 665 funds tracked by Wall St. Rank hold CRL as of Q2 2024.

  • Alta Wealth Advisors reported no remaining Charles River Laboratories position as of Q2 2024 after selling out during the quarter.
  • Alta Wealth Advisors sold 870 Charles River Laboratories shares in Q2 2024, an estimated $236K.
  • Alta Wealth Advisors first reported a position in Charles River Laboratories in Q4 2023 and held it in 2 quarters.
  • Alta Wealth Advisors's Charles River Laboratories position peaked at $236K in Q1 2024.
  • 665 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2024.

Based on Alta Wealth Advisors's 13F filing for Q2 2024, filed 24 Jul 2024.